WGU C785 Biochemistry Exam Prep Document | 2026/2027
Edition | 250 Verified Questions
WGU C785 Biochemistry Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously crafted for the WGU C785
Biochemistry course, featuring 250 verified questions that mirror the real exam's format and content.
Each question is accompanied by detailed rationales to reinforce understanding and ensure mastery of
key biochemical concepts. Designed for the 2026/2027 academic year, this resource is your definitive
guide to achieving a passing score with confidence.
Key Features:
Amino acid structure, properties, and classification
Protein structure and function relationships
Enzyme kinetics and inhibition mechanisms
Metabolic pathways (glycolysis, TCA cycle, oxidative phosphorylation)
DNA replication, transcription, and translation
Molecular techniques and applications in biochemistry
Updates for 2026:
- Revised to align with the latest WGU C785 curriculum changes for 2026/2027
- Incorporated new questions on CRISPR and gene editing technologies
- Updated rationales to reflect current biochemical research and clinical applications
- Enhanced coverage of metabolic regulation and signaling pathways
- Added practice questions on bioinformatics and structural biology tools
Abstract:
This examination preparation resource is an indispensable tool for students enrolled in WGU C785 Biochemistry,
offering a rigorous practice test comprising 250 verified questions that accurately reflect the scope and difficulty of
the actual exam. The content spans fundamental biochemical principles, including the chemistry of biomolecules,
enzyme function, and metabolic integration, with a strong emphasis on clinical correlations and real-world
applications. Each question is paired with a comprehensive rationale that explains not only the correct answer but
also why the distractors are incorrect, facilitating deeper learning and retention. The document is structured to
simulate the exam experience, with questions grouped by content area and weighted to mirror the official exam
blueprint. Updated for the 2026/2027 academic year, this guide incorporates the latest advancements in the field,
ensuring that students are well-prepared for both the exam and future healthcare practice. With a focus on critical
thinking and problem-solving, this resource is a proven pathway to achieving a high score and passing the course
with confidence.
Keywords:
WGU C785, Biochemistry exam, Practice test, Verified questions, Rationales, 2026/2027, Amino acids, Metabolic
pathways
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a detailed rationale
explaining the underlying biochemical principle. Rationales also address common misconceptions and explain why
the incorrect options are not viable, reinforcing the learning process.
Compliance Checklist:
Aligned with WGU C785 course competencies
Page 1
, Updated to reflect 2026/2027 exam guidelines
Includes 250 verified questions with accurate answers
Rationales provided for every question
Content areas weighted to match official exam blueprint
Suitable for self-assessment and exam simulation
Content Area Overview:
Content Area Questions Key Topics Weight
Amino Acids and Proteins 1-50 Amino acid structure, peptide bonds, protein 20%
folding, protein function
Enzymes and Kinetics 51-90 Enzyme catalysis, Michaelis-Menten 16%
kinetics, inhibition, regulation
Carbohydrates and Lipids 91-130 Monosaccharides, polysaccharides, fatty 16%
acids, triglycerides, membranes
Metabolism and Bioenergetics 131-180 Glycolysis, TCA cycle, oxidative 20%
phosphorylation, fatty acid oxidation
Nucleic Acids and Molecular 181-220 DNA structure, replication, transcription, 16%
Biology translation, gene regulation
Advanced Topics and 221-250 Biochemical techniques, clinical 12%
Applications correlations, emerging research
Page 2
,Q1. A researcher identifies a novel enzyme that catalyzes the conversion of substrate
S to product P. Initial velocity data at varying [S] produce a hyperbolic curve. When
the enzyme is incubated with an inhibitor, the apparent Km increases while Vmax
remains unchanged. Which kinetic parameter change is consistent with this inhibitor
behaving as competitive?
A. Increase in Km and decrease in Vmax
B. Increase in Km with no change in Vmax
C. Decrease in Km and decrease in Vmax
D. No change in Km but decrease in Vmax
Correct Answer: B. Increase in Km with no change in Vmax
Rationale: Competitive inhibitors bind to the active site, increasing the apparent Km
(more substrate needed to reach half Vmax) while leaving Vmax unchanged, as high
substrate can outcompete the inhibitor. Option B correctly reflects this. Option A describes
noncompetitive inhibition (decreased Vmax), option C is uncompetitive-like, and option D
describes pure noncompetitive inhibition.
Why Wrong:
A - A decrease in Vmax indicates noncompetitive or mixed inhibition, not
competitive.
C - A decrease in Km would indicate increased affinity, not typical of competitive
inhibition.
D - A decrease in Vmax without Km change is characteristic of noncompetitive
inhibition.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 6: Enzyme Inhibition
Q2. A patient with a genetic deficiency in branched-chain alpha-keto acid
dehydrogenase (BCKDH) accumulates leucine, isoleucine, and valine. Which of the
following best explains why this enzyme deficiency leads to severe neurological
dysfunction despite normal blood glucose levels?
A. Accumulation of toxic keto acids disrupts the citric acid cycle by inhibiting
alpha-ketoglutarate dehydrogenase
B. Deficiency of acetyl-CoA and acetoacetate production impairs ketone body
synthesis, forcing brain to rely solely on glucose
C. Excess branched-chain amino acids inhibit pyruvate carboxylase, reducing
gluconeogenesis
D. Accumulation of branched-chain amino acids leads to competitive inhibition of
neurotransmitter transporters at the blood-brain barrier
Correct Answer: B. Deficiency of acetyl-CoA and acetoacetate production impairs
ketone body synthesis, forcing brain to rely solely on glucose
Page 3
, Rationale: BCKDH is essential for catabolism of branched-chain amino acids to produce
acetyl-CoA and acetoacetate, precursors for ketone bodies. Deficiency impairs ketone
body synthesis, which are crucial alternative fuels for the brain during fasting. While toxic
metabolites also play a role, the primary metabolic consequence is impaired ketogenesis,
not direct TCA inhibition. Option B captures this. Option A is less direct; the main issue is
fuel deficiency, not TCA inhibition.
Why Wrong:
A - Inhibition of alpha-ketoglutarate dehydrogenase is not the primary mechanism in
BCKDH deficiency.
C - Pyruvate carboxylase is not directly inhibited by branched-chain amino acids in
this disorder.
D - Competitive inhibition of neurotransmitter transporters is not a recognized major
consequence.
Reference: Lieberman, M., & Peet, A. (2021). Marks' Basic Medical Biochemistry, 6th Ed.,
Ch. 19
Q3. A 45-year-old adult presents with fatigue, muscle weakness, and elevated serum
creatine kinase. Muscle biopsy shows glycogen accumulation. Enzymatic assay reveals
a deficiency in debranching enzyme (amylo-1,6-glucosidase). Which metabolic
pathway is most directly impaired?
A. Glycogenolysis in the liver and muscle, specifically the breakdown of alpha-1,6
branch points
B. Glycogen synthesis, specifically the formation of alpha-1,6 linkages
C. Glycolysis, specifically the conversion of glucose-6-phosphate to
fructose-6-phosphate
D. Gluconeogenesis, specifically the conversion of pyruvate to oxaloacetate
Correct Answer: A. Glycogenolysis in the liver and muscle, specifically the
breakdown of alpha-1,6 branch points
Rationale: Debranching enzyme is required for glycogenolysis to break alpha-1,6 linkages
at branch points, allowing further phosphorylase action. Deficiency leads to incomplete
glycogen breakdown and accumulation of abnormal glycogen. Option A identifies the
correct pathway. Option B refers to glycogen synthesis (branching enzyme), C and D are
unrelated to debranching enzyme.
Why Wrong:
B - Formation of alpha-1,6 linkages is catalyzed by branching enzyme, not
debranching enzyme.
C - Conversion of glucose-6-phosphate to fructose-6-phosphate is a glycolysis step,
not directly affected.
D - Gluconeogenesis from pyruvate is not impaired in debranching enzyme
deficiency.
Page 4
Edition | 250 Verified Questions
WGU C785 Biochemistry Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously crafted for the WGU C785
Biochemistry course, featuring 250 verified questions that mirror the real exam's format and content.
Each question is accompanied by detailed rationales to reinforce understanding and ensure mastery of
key biochemical concepts. Designed for the 2026/2027 academic year, this resource is your definitive
guide to achieving a passing score with confidence.
Key Features:
Amino acid structure, properties, and classification
Protein structure and function relationships
Enzyme kinetics and inhibition mechanisms
Metabolic pathways (glycolysis, TCA cycle, oxidative phosphorylation)
DNA replication, transcription, and translation
Molecular techniques and applications in biochemistry
Updates for 2026:
- Revised to align with the latest WGU C785 curriculum changes for 2026/2027
- Incorporated new questions on CRISPR and gene editing technologies
- Updated rationales to reflect current biochemical research and clinical applications
- Enhanced coverage of metabolic regulation and signaling pathways
- Added practice questions on bioinformatics and structural biology tools
Abstract:
This examination preparation resource is an indispensable tool for students enrolled in WGU C785 Biochemistry,
offering a rigorous practice test comprising 250 verified questions that accurately reflect the scope and difficulty of
the actual exam. The content spans fundamental biochemical principles, including the chemistry of biomolecules,
enzyme function, and metabolic integration, with a strong emphasis on clinical correlations and real-world
applications. Each question is paired with a comprehensive rationale that explains not only the correct answer but
also why the distractors are incorrect, facilitating deeper learning and retention. The document is structured to
simulate the exam experience, with questions grouped by content area and weighted to mirror the official exam
blueprint. Updated for the 2026/2027 academic year, this guide incorporates the latest advancements in the field,
ensuring that students are well-prepared for both the exam and future healthcare practice. With a focus on critical
thinking and problem-solving, this resource is a proven pathway to achieving a high score and passing the course
with confidence.
Keywords:
WGU C785, Biochemistry exam, Practice test, Verified questions, Rationales, 2026/2027, Amino acids, Metabolic
pathways
Answer Format:
Each question is presented in a multiple-choice format, followed by the correct answer and a detailed rationale
explaining the underlying biochemical principle. Rationales also address common misconceptions and explain why
the incorrect options are not viable, reinforcing the learning process.
Compliance Checklist:
Aligned with WGU C785 course competencies
Page 1
, Updated to reflect 2026/2027 exam guidelines
Includes 250 verified questions with accurate answers
Rationales provided for every question
Content areas weighted to match official exam blueprint
Suitable for self-assessment and exam simulation
Content Area Overview:
Content Area Questions Key Topics Weight
Amino Acids and Proteins 1-50 Amino acid structure, peptide bonds, protein 20%
folding, protein function
Enzymes and Kinetics 51-90 Enzyme catalysis, Michaelis-Menten 16%
kinetics, inhibition, regulation
Carbohydrates and Lipids 91-130 Monosaccharides, polysaccharides, fatty 16%
acids, triglycerides, membranes
Metabolism and Bioenergetics 131-180 Glycolysis, TCA cycle, oxidative 20%
phosphorylation, fatty acid oxidation
Nucleic Acids and Molecular 181-220 DNA structure, replication, transcription, 16%
Biology translation, gene regulation
Advanced Topics and 221-250 Biochemical techniques, clinical 12%
Applications correlations, emerging research
Page 2
,Q1. A researcher identifies a novel enzyme that catalyzes the conversion of substrate
S to product P. Initial velocity data at varying [S] produce a hyperbolic curve. When
the enzyme is incubated with an inhibitor, the apparent Km increases while Vmax
remains unchanged. Which kinetic parameter change is consistent with this inhibitor
behaving as competitive?
A. Increase in Km and decrease in Vmax
B. Increase in Km with no change in Vmax
C. Decrease in Km and decrease in Vmax
D. No change in Km but decrease in Vmax
Correct Answer: B. Increase in Km with no change in Vmax
Rationale: Competitive inhibitors bind to the active site, increasing the apparent Km
(more substrate needed to reach half Vmax) while leaving Vmax unchanged, as high
substrate can outcompete the inhibitor. Option B correctly reflects this. Option A describes
noncompetitive inhibition (decreased Vmax), option C is uncompetitive-like, and option D
describes pure noncompetitive inhibition.
Why Wrong:
A - A decrease in Vmax indicates noncompetitive or mixed inhibition, not
competitive.
C - A decrease in Km would indicate increased affinity, not typical of competitive
inhibition.
D - A decrease in Vmax without Km change is characteristic of noncompetitive
inhibition.
Reference: Lehninger Principles of Biochemistry, 8th Ed., Ch. 6: Enzyme Inhibition
Q2. A patient with a genetic deficiency in branched-chain alpha-keto acid
dehydrogenase (BCKDH) accumulates leucine, isoleucine, and valine. Which of the
following best explains why this enzyme deficiency leads to severe neurological
dysfunction despite normal blood glucose levels?
A. Accumulation of toxic keto acids disrupts the citric acid cycle by inhibiting
alpha-ketoglutarate dehydrogenase
B. Deficiency of acetyl-CoA and acetoacetate production impairs ketone body
synthesis, forcing brain to rely solely on glucose
C. Excess branched-chain amino acids inhibit pyruvate carboxylase, reducing
gluconeogenesis
D. Accumulation of branched-chain amino acids leads to competitive inhibition of
neurotransmitter transporters at the blood-brain barrier
Correct Answer: B. Deficiency of acetyl-CoA and acetoacetate production impairs
ketone body synthesis, forcing brain to rely solely on glucose
Page 3
, Rationale: BCKDH is essential for catabolism of branched-chain amino acids to produce
acetyl-CoA and acetoacetate, precursors for ketone bodies. Deficiency impairs ketone
body synthesis, which are crucial alternative fuels for the brain during fasting. While toxic
metabolites also play a role, the primary metabolic consequence is impaired ketogenesis,
not direct TCA inhibition. Option B captures this. Option A is less direct; the main issue is
fuel deficiency, not TCA inhibition.
Why Wrong:
A - Inhibition of alpha-ketoglutarate dehydrogenase is not the primary mechanism in
BCKDH deficiency.
C - Pyruvate carboxylase is not directly inhibited by branched-chain amino acids in
this disorder.
D - Competitive inhibition of neurotransmitter transporters is not a recognized major
consequence.
Reference: Lieberman, M., & Peet, A. (2021). Marks' Basic Medical Biochemistry, 6th Ed.,
Ch. 19
Q3. A 45-year-old adult presents with fatigue, muscle weakness, and elevated serum
creatine kinase. Muscle biopsy shows glycogen accumulation. Enzymatic assay reveals
a deficiency in debranching enzyme (amylo-1,6-glucosidase). Which metabolic
pathway is most directly impaired?
A. Glycogenolysis in the liver and muscle, specifically the breakdown of alpha-1,6
branch points
B. Glycogen synthesis, specifically the formation of alpha-1,6 linkages
C. Glycolysis, specifically the conversion of glucose-6-phosphate to
fructose-6-phosphate
D. Gluconeogenesis, specifically the conversion of pyruvate to oxaloacetate
Correct Answer: A. Glycogenolysis in the liver and muscle, specifically the
breakdown of alpha-1,6 branch points
Rationale: Debranching enzyme is required for glycogenolysis to break alpha-1,6 linkages
at branch points, allowing further phosphorylase action. Deficiency leads to incomplete
glycogen breakdown and accumulation of abnormal glycogen. Option A identifies the
correct pathway. Option B refers to glycogen synthesis (branching enzyme), C and D are
unrelated to debranching enzyme.
Why Wrong:
B - Formation of alpha-1,6 linkages is catalyzed by branching enzyme, not
debranching enzyme.
C - Conversion of glucose-6-phosphate to fructose-6-phosphate is a glycolysis step,
not directly affected.
D - Gluconeogenesis from pyruvate is not impaired in debranching enzyme
deficiency.
Page 4
